These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28160485)

  • 41. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Greater response to cardiac resynchronization therapy in patients with true complete left bundle branch block: a PREDICT substudy.
    Perrin MJ; Green MS; Redpath CJ; Nery PB; Keren A; Beanlands RS; Birnie DH
    Europace; 2012 May; 14(5):690-5. PubMed ID: 22170897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy.
    Alpendurada F; Guha K; Sharma R; Ismail TF; Clifford A; Banya W; Mohiaddin RH; Pennell DJ; Cowie MR; McDonagh T; Prasad SK
    J Cardiovasc Magn Reson; 2011 Oct; 13(1):68. PubMed ID: 22040270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic importance of postoperative QRS widening in patients with heart failure receiving cardiac resynchronization therapy.
    Menet A; Bardet-Bouchery H; Guyomar Y; Graux P; Delelis F; Castel AL; Heuls S; Cuvelier E; Gevaert C; Ennezat PV; Tribouilloy C; Maréchaux S
    Heart Rhythm; 2016 Aug; 13(8):1636-43. PubMed ID: 27236025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score.
    Bakos Z; Chatterjee NC; Reitan C; Singh JP; Borgquist R
    BMC Cardiovasc Disord; 2018 Apr; 18(1):70. PubMed ID: 29699498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.
    Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac resynchronization therapy in adults with congenital heart disease.
    Koyak Z; de Groot JR; Krimly A; Mackay TM; Bouma BJ; Silversides CK; Oechslin EN; Hoke U; van Erven L; Budts W; Van Gelder IC; Mulder BJM; Harris L
    Europace; 2018 Feb; 20(2):315-322. PubMed ID: 28108550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.
    van der Bijl P; Khidir M; Leung M; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Eur J Heart Fail; 2017 Sep; 19(9):1145-1151. PubMed ID: 28176418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The ECG in cardiac resynchronization therapy: influence of left and right ventricular preactivation and relation to acute response.
    Bogaard MD; Hesselink T; Meine M; Loh P; Hauer RN; Cramer MJ; Doevendans PA; Tuinenburg AE
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1237-45. PubMed ID: 22734629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Shortest QRS Duration of an Electrocardiogram Might Be an Optimal Electrocardiographic Predictor for Response to Cardiac Resynchronization Therapy.
    Chen JY; Lin KH; Chang KC; Chou CY
    Int Heart J; 2017 Aug; 58(4):530-535. PubMed ID: 28701672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Role of electrocardiogram in predicting cardiac resynchronization therapy response].
    Guo JP; Wang YT; Shan ZL; Shi XM; Lin K; Yuan HT; Li J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jun; 44(6):483-8. PubMed ID: 27346260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy.
    Iler MA; Hu T; Ayyagari S; Callahan TD; Civello KC; Thal SG; Wilkoff BL; Chung MK
    Am J Cardiol; 2008 Feb; 101(3):359-63. PubMed ID: 18237600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of multidisciplinary cardiac rehabilitation on the response to cardiac resynchronization therapy.
    Martens P; Jacobs G; Dupont M; Mullens W
    Cardiovasc Ther; 2018 Dec; 36(6):e12467. PubMed ID: 30239134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Electrocardiographic predictors of response to cardiac resynchronization therapy of heart failure in patients with dilated cardiomyopathy].
    Vaĭkhanskaia TG; Kurushko TV; Sidorenko IV; Koptiukh TM; Gul' LM; Mel'nikova OP; Golenishcha VF; Kovalenko ON
    Kardiologiia; 2013; 53(3):48-54. PubMed ID: 23548427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
    van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ventricular high-rate episodes predict increased mortality in heart failure patients treated with cardiac resynchronization therapy.
    Jacobsson J; Reitan C; Platonov PG; Borgquist R
    Scand Cardiovasc J; 2015 Feb; 49(1):20-6. PubMed ID: 25658030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval: MADIT-CRT long-term follow-up.
    Stockburger M; Moss AJ; Klein HU; Zareba W; Goldenberg I; Biton Y; McNitt S; Kutyifa V
    Clin Res Cardiol; 2016 Nov; 105(11):944-952. PubMed ID: 27318807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Echocardiographic and clinical response to cardiac resynchronization therapy in heart failure patients with and without previous right ventricular pacing.
    Gage RM; Burns KV; Bank AJ
    Eur J Heart Fail; 2014 Nov; 16(11):1199-205. PubMed ID: 25132044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.